Recently, radiation therapy practice has incorporated improvements in computers and networking, radiation therapy treatment planning software, and medical imaging modalities (such as, computed tomography (“CT”), magnetic resonance imaging (“MRI”), ultrasound (“US”), and positron emission tomography (“PET”)). In some cases, techniques are used for the planning and delivery of radiation therapy. For example, a method of treating a moving target, such as a tumor of a lung, can include “gating,” or delivering radiation only when the target is within a specified window of trajectory. This method is inefficient because the target is only being irradiated for periodic intervals of time.
Another method of treating a moving target is referred to as breathing synchronized delivery (“BSD”). This technique utilizes an anticipated track, or path of motion, for a target to follow during treatment. To do so, a plan is developed that assumes the target will remain on the anticipated track, which has an anticipated period and phase throughout the entire treatment plan. Audio and visual guidance can be used to prompt a patient to follow the rigidly defined track. However, following a strictly defined pattern may be difficult for a large portion of radiation therapy patients.
Radiation can be delivered to a moving region of interest without relying upon a priori knowledge of the region's location, period, and phase. Dynamic switching between a plurality of plans, or developing plans “on the fly” can be used to reflect changes in a patient's anatomical motion and apply a radiation treatment more effectively.
In one embodiment, the invention provides a method of detecting a breathing phase of a patient receiving radiation therapy. The method includes the acts of obtaining a plurality of patient images representing phases of a breathing cycle, delivering radiation to the patient, collecting transmission data of the patient during the delivering radiation, and comparing the transmission data to the plurality of patient images.
In another embodiment, the invention provides a system for detecting a breathing phase of a patient receiving radiation therapy. The system comprises a radiation therapy device including a computer processor, a radiation source operable to deliver radiation to the patient, and a radiation detector operable to collect transmission radiation. The system further comprises a software program stored in a computer readable medium accessible by the computer processor. The software program is operable to obtain a plurality of patient images representing phases of a breathing cycle, obtain transmission data of the patient from the collected transmission radiation, and compare the transmission data to the plurality of patient images.
Other aspects of the invention will become apparent by consideration of the detailed description and accompanying drawings.
Before any embodiments of the invention are explained in detail, it is to be understood that the invention is not limited in its application to the details of construction and the arrangement of components set forth in the following description or illustrated in the following drawings. The invention is capable of other embodiments and of being practiced or of being carried out in various ways. Also, it is to be understood that the phraseology and terminology used herein is for the purpose of description and should not be regarded as limiting. The use of “including,” “comprising,” or “having” and variations thereof herein is meant to encompass the items listed thereafter and equivalents thereof as well as additional items. Unless specified or limited otherwise, the terms “mounted,” “connected,” “supported,” and “coupled” and variations thereof herein are used broadly and encompass both direct and indirect mountings, connections, supports, and couplings. Further, “connected” and “coupled” are not restricted to physical or mechanical connections or couplings.
Although directional references, such as upper, lower, downward, upward, rearward, bottom, front, rear, etc., may be made herein in describing the drawings, these references are made relative to the drawings (as normally viewed) for convenience. These directions are not intended to be taken literally or limit the invention in any form. In addition, terms such as “first”, “second”, and “third” are used herein for purposes of description and are not intended to indicate or imply relative importance or significance.
In addition, it should be understood that embodiments of the invention include both hardware, software, and electronic components or modules that, for purposes of discussion, may be illustrated and described as if the majority of the components were implemented solely in hardware. However, one of ordinary skill in the art, and based on a reading of this detailed description, would recognize that, in at least one embodiment, the electronic based aspects of the invention may be implemented in software. As such, it should be noted that a plurality of hardware and software based devices, as well as a plurality of different structural components may be utilized to implement the invention. Furthermore, and as described in subsequent paragraphs, the specific mechanical configurations illustrated in the drawings are intended to exemplify embodiments of the invention and that other alternative mechanical configurations are possible.
The gantry 22 can support a radiation module, having a radiation source 26 and a linear accelerator 30 operable to generate a beam 34 of photon radiation. The radiation module can also include a modulation device 42 operable to modify or modulate the radiation beam 34. The modulation device 42 provides the modulation of the radiation beam 34 and directs the radiation beam 34 toward the patient 14. Specifically, the radiation beam 34 is directed toward a portion of the patient. Broadly speaking, the portion may include the entire body, but is generally smaller than the entire body and can be defined by a two-dimensional area and/or a three-dimensional volume. A portion desired to receive the radiation, which may be referred to as a target or target region (shown as 54), is an example of a region of interest. Another type of region of interest is a region at risk. If a portion includes a region at risk, the radiation beam is preferably diverted from the region at risk. The patient 14 may have more than one target region 54 that needs to receive radiation therapy. Such modulation is sometimes referred to as intensity modulated radiation therapy (“IMRT”).
Other frameworks capable of positioning the radiation module at various rotational and/or axial positions relative to the patient 14 may also be employed. In addition, the radiation module may travel in path that does not follow the shape of the gantry 22. For example, the radiation module may travel in a non-circular path even though the illustrated gantry 22 is generally circular-shaped.
In one construction, and illustrated in
The radiation therapy treatment system 10 can also include a detector 66, e.g., a kilovoltage or a megavoltage detector, operable to receive a radiation beam from the radiation module or from a separate radiation source. The radiation module and the detector 66 can potentially operate as a computed tomography (CT) system to generate CT images of the patient 14. The radiation module emits the radiation beam 34 toward the target 54 in the patient 14. The CT images can be acquired with a radiation beam 34 that has a fan-shaped geometry, a multi-slice geometry, or a cone-beam geometry. In addition, the CT images can be acquired with the linear accelerator 30 delivering megavoltage energies or kilovoltage energies. The target 54 and surrounding tissues absorb some of the radiation.
The radiation therapy treatment system 10 can also include a patient support, such as a couch 70 (illustrated in
The computer 62 includes an operating system for running various software programs and/or communication applications. In particular, the computer 62 can include a software program 78 operable to communicate with the radiation therapy device 18. The computer 62 can include any suitable input/output device adapted to be accessed by medical personnel. The computer 62 can include hardware such as a processor, I/O interfaces, and storage devices or memory. The computer 62 can also include input devices such as a keyboard and a mouse. The computer 62 can further include output devices, such as a monitor. In addition, the computer 62 can include peripherals, such as a printer and a scanner.
The radiation therapy device 18 communicates directly with the computer 62, and/or via a network 82, as illustrated in
The network 82 can be built according to any networking technology or topology or combinations of technologies and topologies and can include multiple sub-networks. Connections between the computers 62 and device 18 shown in
Communication between the computers 62 and radiation therapy devices 18 shown in
The two-way arrows in
The multi-leaf collimator, as described above, can provide intensity modulation of the radiation beam 34 to accommodate varying conditions and regions of interest. More specifically, the intensity of the radiation beam 34 can be increased or decreased by moving the leaves 50 of the multi-leaf collimator 46. However, a target 54 that is in motion (e.g., a tumor of a lung, a heart, a digestive track, etc.) is difficult to treat with a continuous beam 34 because it does not often move in a repeated pattern.
The software program 78 can accommodate a moving region of interest by varying the amount of radiation that is delivered to the patient 14 in accordance with the actual movement of the region of interest, as described below. An exemplary software program 78 is schematically illustrated in
One implementation is to begin by optimizing a BSD-type treatment, which assumes a target trajectory, breathing phase, and period throughout the treatment. However, in addition to optimizing that one plan, an additional set of plans can be optimized, each potentially with a different period, breathing phase, or other parameter varying with respect to the base BSD plan. Then, during treatment the patient begins by attempting to follow the target trace indicated in the BSD plan. However, if the patient's breathing deviates from this plan by more than a specified threshold, then the plan automatically switches to one of the alternate plans better matching the current region parameters. The delivery for an arbitrary patient breathing trace is illustrated by the thick line in
In another implementation, rather than following a base four-dimensional (“4D”) plan, the plans automatically switch as the patient breathes freely through the delivery. If desired, particularly erratic breathing, such as coughing, can be identified and the treatment may temporarily delay until the breathing again falls within specified tolerances. Similarly, if there are phases of breathing or regions of motion where the position of the region of interest is not well-defined, then treatment could be intentionally avoided during those phases. Such a decision may be made during planning, but can also be made dynamically, based upon perceived changes in the patient's anatomy of physiology.
A series of plans is generated with different possible criteria. All the plans, or many possible combinations of them, are maintained on the system 10 to be delivered whenever necessary. The breathing pattern is evaluated by an adequate evaluation device and based on real time decisions, potentially in conjunction with prior evaluation, based upon anticipated breathing scenarios. The system 10 evaluates and selects a plan or plan combination to be delivered. The selected plan can be accumulated with the previous fractions or part of the treatment previously delivered. As the plan is delivered, information can be recorded (or used for instance in conjunction with real time dose reconstruction) and potentially used to refine any plans for delivering future radiation (either during the current session or future sessions).
A. Optimization module
One method for optimization, as mentioned above, is to optimize sets of 4D plans, each representing a different phase of motion (or period, etc.) Breathing cycles can be described and/or approximated by an infinite or finite Fourier expansion. In one possible implementation of the optimization module 95, a particular breathing cycle is described as a function of time of a linear combination of sine and cosine type functions having different frequency, amplitude, phases, etc. that evolves on time (See, e.g.,
In another implementation of the optimization module 95, the plans need not each represent a complete 4D plan for a given parameter (e.g. period or trajectory), but the set of plans each represent a static delivery appropriate for a single phase of the motion cycle. The plans would automatically switch as the region of interest moves through its different motion phases. It is similarly possible to interpolate between phases in order to generate more images, optimize a larger number of phase-plans, and/or select a phase-specific plan.
Furthermore, it is possible to have multiple plans available for any given phase or set of parameters that utilize different optimization criteria. For example, rather than optimizing just one plan for each breathing phase, it is possible to optimize multiple sets of plans. This might entail having one plan for each breathing phase with a tight margin, and other plans for each breathing phase with wider margins (or with other constraints changing). As the treatment proceeds, the plan can be dynamically chosen based both on the region's of interest position, period, and/or phase, but also based upon its speed, uncertainty, and/or deformation. In cases where the target 54 is well-defined, plans from the narrow-margin set may be dynamically selected; whereas in cases of less certainty, larger margin plans may be selected.
One method of optimizing doses across multiple phase images is for the optimization module 95 to calculate dose beamlets for each phase, and then deform the beamlets in accordance with image deformation maps that relate the images. Although this method can be applied, it is not necessary, as doses can be calculated for each phase, and then added using deformation, such that deformation-adjusted beamlets are not required.
B. Plan Selection Module
The method for selecting the plan can be based upon a number of possible criteria. In one implementation of the plan selection module 142, the plan is based on criteria discussed above, such as the region's of interest position, period, and/or phase, each of which can be acquired by a motion detection device 89 and the acquisition module 94. Likewise, uncertainty and/or anatomical information can also be incorporated. The measurements are obtained from an applicable device, such as, but not limited to, camera systems, laser systems, X-Ray or fluoro systems, CT, MRI, PET, single photon emission computed tomography (“SPECT”), on-line CT, cone-beam CT, implanted markers, radiofrequency (“RF”) localizers, ultrasound, breathing belts or cuffs, implanted X-Ray sources, acoustic sensors, strain gauges, RF emitters, and electrode based impedance measurements.
In another implementation, the plan selection module 142 selects plans based upon dosimetric characteristics. More specifically, a desired dose distribution is defined for each optimized plan section. Then during treatment, the plan selection module 142 determines which of the available plans would best match the planned dose given the patient's current anatomy and target information. This calculation can involve real-time dose calculations, but can be approximated by simplified or pre-computed calculations.
In yet another implementation, the plan selection module incorporates deformation with pre-computed calculations. This implementation relates dose in physical space to dose in specific tissues/targets. By incorporating deformation, it is easier to select plans that match the intended dose distributions in specific regions. Example deformation techniques and calculations are described in U.S. Provisional Patent Application No. 60/701,580; filed Jul. 22, 2005; titled SYSTEM AND METHOD FOR FEEDBACK GUIDED QUALITY ASSURANCE AND ADAPTATIONS TO RADIATION THERAPY TREATMENT, the entire content of which is incorporated herein by reference.
In another implementation that may also entail deformation, the desired dose is not only attempted to match the planned dose, but the plan selection module 142 simultaneously seeks to remedy any dose discrepancies from previous fractions or earlier in the fraction being delivered.
In another implementation of the plan selection module 142, the dynamic plan selection is not based solely upon matching the dose distribution (or cumulative dose distribution, deformed dose distribution, or deformed cumulative dose distribution), but also uses other criteria, such as target dose, sensitive structure dose, or dose-volume histograms (“DVHs”). Similarly, the plan selection is also based upon achieving a given biological outcome. And in this implementation, biological estimators are incorporated into the dose accumulation and/or plan selection process. The plan selection module 142 can also incorporate biological and clinical feedback regarding the patient, to facilitate the use of more aggressive plans in regions, times, or patients, where these plans might be better tolerated, and more conservative plans in more sensitive locations, times, or patients.
The dynamic plan selection of the plan selection module also need not be based solely on the patient's current information, but can use past information to account for lags in measurement and deliver a plan with appropriate anticipation of anatomical changes and compensating for delays in measurement and processing.
In another implementation of the software program 78, some or all of the dynamically selectable plans are not optimized in advance. With a fast optimizer, some of these plans are generated during the application of radiation therapy. Similarly, existing plans are modified during the application of radiation therapy to reflect physiological or anatomical changes. In other words, the optimization module 95 and the plan selection module 142 can closely interact (or be integrated) to provide a fast optimizer and selection module.
C. Acquisition Module Including a Mechanical Tracking Sub-Module
The tracking of the patient's breathing phase or motion status can be performed with many of the numerous motion detection devices and related acquisition software for tracking patient physiology. The acquisition module 94 can include a motion or mechanical tracking sub-module 96. Example motion detection devices include, but not limited to, spirometers, camera systems, stereoscopic cameras, laser systems, fluoroscopy, X-Ray systems, CT, implanted markers, RF markers, MRI, strain gauges, and electrode impedance measurements.
In one implementation of the acquisition module 94, instead of or addition to the just-describe tracking methods, the tracking is also performed with data collected during the delivery, such as through a megavoltage CT, a kilovoltage CT, or a cone-beam CT system. The mechanical tracking module 96 processes the data from these systems to identify the location, phase, and position of the region of interest, and also the patient's breathing phase and anatomical changes. The information is extracted either from the reconstructed images, from the projection data, or from a hybrid of reconstructions and projection data. This implementation may also incorporate a priori information from previous or generic images or projection data sets.
For example, a 4D model of tumor trajectory is established from the planning images, and this model is verified with the projection data, as well as identifying the patient's present breathing phase. Sinograms are checked for the presence and location of the structures or markers of interest. This information identifies the current or recent patient breathing phases, the location of the tumor, whether the tumor is off any predicted geographic or temporal track and what other plans might be useful for delivering dose in the present or future anatomy. This information can also be used to detect locations, via magnification, in single or orthogonal portal/CT projections.
In another implementation, the mechanical tracking sub-module 96 uses the information to analyze various delays (measuring position, measuring couch, etc.) that can be accounted for in the plan selection. This information can also verify that an anticipated target 54 (or region of interest) trajectory remains valid, and can distinguish low-frequency (base motion) from high-frequency (noise, irregularities) to estimate appropriate amounts of compensation. In some implementations of the mechanical tracking sub-module 96, the compensation is partially achieved through dynamic couch corrections.
When using transmitted radiation for detection of phase and/or position, it is preferable to minimize unnecessary radiation. For this reason, one implementation of the acquisition module 94 uses the radiation being delivered as part of the treatment. The data is generally limited in scope, as the treatments are typically intended only to deliver radiation to target regions 54. However, the amount of obtained data may be adequate for identifying the necessary features, positions, or phases of the region of interest.
In another implementation, the acquisition module 94 acquires additional information obtained from briefly “flashing” additional MLC leaves open to create transmission data for a larger region of the patient. This can be done more often, or with a larger number of leaves, when more data is needed; or it can be done less frequently, or with fewer leaves, providing less information, but sparing dose and verifying as necessary. When using fewer leaves, or reduced frequency, it may be that localizations are better known, other devices are also being used, the treatment quality is less dependent on the changes being verified, or for other reasons.
The principle of reduced dose can also be applied to imaging systems without MLCs attached. For example, if an additional source (such as an X-Ray source) and a detector are being used for verification, it is known in the art that such a system is used to track motion, and phase in some cases, by running the system in fluoroscopic mode. However, this contributes a very high dose to the patient. Thus, in another implementation, the mechanical tracking sub-module 96 detects and verifies phase and/or position information with a very slow or discrete fluoroscopy use, as opposed to continuous use. For example, rather than using continuous tracking, fluoroscopy frames are taken at specific times to determine or corroborate a target (or region of interest) position or phase. These times may be equally spaced, or they may be spaced based upon other patient feedback, or spaced based on anticipated motion phases or locations. As such, this implementation can be used for independent measurement, or can be used to corroborate external or surrogate-based verification devices with low-dose internal images.
1. Real-Time Respiratory Motion Monitoring via Intensity Modulated Radiation Therapy (“IMRT”)
Real time tracking of tumor position or monitoring motion of internal organs is important for extending radiation therapy from three dimensional (“3D”) to four dimensional (“4D”). All 4D radiotherapy techniques, whether based on gating, tracking, BSD, or the free-breathing delivery (“FBD”) technique, require the real time knowledge of the breathing states, or at least the tumor position. Some available respiratory monitoring techniques include marker methods and airflow methods. Both methods indirectly monitor respiratory motion by some kind of surrogate. The marker methods use external or internal markers as the surrogate. Cameras (for external markers) or fluoroscopy devices (for internal markers) are used to track these markers. The airflow methods use a pyrometer to measure the airflow during breathing, and the airflow is used as the surrogate for respiratory motion. The disadvantages of these surrogate methods include: 1) how well the surrogate correlates to the internal respiratory motion and what kind of correlation are doubtful; 2) the respiratory motion is a complicated 4D deformation process, therefore, a surrogate with one or few parameters have very limited representation for the respiratory motion of a large body section; and 3) there exist (potentially unstable) delays between the surrogate and the respiratory motion.
One alternative method includes a direct method to monitor the respiratory motion. The method directly monitors the internal organ motion with respect to the treatment beam. The method can be implemented directly in the system 10 with a detector system. An example of a detector system is the HI-ART brand radiation therapy system offered by TomoTherapy, Inc. with a web site at www.tomotherapy.com. No additional devices, such as a camera, a spirometer, or a fluoroscopy device, are required. No extra radiation is necessary.
For example, a radiation therapy treatment system may have a complete set of 3D images, each 3D image being a snapshot of the patient at certain breathing states (or phases). A planning fluence map (or sinogram) is typically available before the treatment. Based on a 3D representation of the patient, for each projection (line) of the planning sinogram, the computer 62 calculates the detector response (output signal) by direct ray tracing or Monte-Carlo simulation. Therefore, for all N phases of the 4D image, the system precalculates N output signals for each projection. After doing the precalculation, the monitoring of respiratory motion is straightforward. The system need only to compare the real detector signal with the precalculated N detector signals, the one with the largest similarity measure gives the breathing phase at that time. A simple correlation could be used as the similarity measure. The correlation can be defined as:
where
si is the precalculated detected signal corresponding to the ith phase,
s is the measured detected signal,
and
wherein the detector signal states for a vector of the signals from all detectors.
D. Delivery Module Including a Mechanical Control Sub-Module
In some constructions, mechanical methods can be used for correcting the free-breathing techniques described above, or used with conventional plans (e.g. static plans, breath-hold plans, etc.). For example, the primary collimator 38 can follow the motion of the regions of interest along with the modulation device 42 modulating the beam. As another example, the couch 70 can be used to facilitate dynamic repositioning.
In one construction, the mechanical tracking module 96 continuously determines the patient phase throughout the delivery. The offset of any relevant structures from the planning position is determined by a mechanical control sub-module 99 of the delivery module 97. The sub-module 99 decomposes the offset into a transversal component and a longitudinal component. A target 54 affected by motions on the inferior-superior direction during treatment (the more common) is accounted by moving the primary collimator 38. The primary collimator 38 can include a set of jaws before the modulation device 42. The jaws define and adjust the size of an aperture through which the radiation beam may pass. Alternatively, a segmented primary collimation allows creating shapes that follow the target 54 and the beam is modulated by the modulation device 42. Couch motion can also be used in combination to either create other motions or extend the degree of motion.
A difference with other mechanical techniques to correct motion is that the one presented here does not use the modulation device 42 to account for motion on the inferior-superior direction. The primary collimator 38 is used to follow the motion on this direction, alone or in combination with the couch 70. One of the advantages is that, in principle, no plan changes are necessary to correct for this motion (except for a few adjustments on the output for different directions). However, this technique can also be incorporated into the dynamic plan modification or switching methods described herein. In addition, dynamic plans can be optimized for different collimator positions to incorporate any beam changes relevant to the different jaw locations. In another implementation, the mechanical control sub-module 99 models changes without separate plans.
Corrections for motions in other (non inferior-superior) directions can also be accounted for. Corrections in the beam direction are corrected either with the couch 70 or by a simple change of the MLC modulation time accounted for inverse square corrections. Couch motion can also be used to account for this motion alone or in conjunction with MLC time changes.
Motions on the plane perpendicular to the beam (i.e., not the inferior-superior direction) can be accounted for by either changing the leaf pattern or by a combination of leaf pattern and couch motion. It should be noted that mechanical motions, such as collimator motion, can be either incorporated into the planning process, or performed in response to detected motion. That is, in some cases, the collimator motion is pre-programmed based upon the anticipated patient breathing trace. Yet, either the collimator motion or plan is dynamically altered if the patient's motion does not follow the anticipated trace. In other cases, motion of the collimator 38 is a purely compensatory method for patient motion deviations. Under these conditions, the target 54 and sensitive structure motions are accounted for in real time. It is envisioned that changing the motion of the collimator 38 or changing the leaf pattern may result in a reordering of the treatment plan or scaling of the treatment plan.
E. Patient Feedback Module
Although various techniques described herein are designed to free a patient from the constraint of a required breathing pattern, this does not require that a patient breathe without any assistance from a guidance system, or without any “target” breathing traces. Instead, in some constructions of the system 100, even if a patient deviates from an intended breathing track, the treatment dynamically adjusts accordingly.
To this extent, a patient feedback module 100 can provide the patient with feedback on their motion control, and potentially guidance signals. This can be performed using a goggle system, a video projection inside or visible from the gantry (potentially visible through mirror glasses or an auxiliary device), audio feedback, or the like.
A patient feedback module 100 can also assist patient motion by having the patient willfully breathe under assistance by a respirator. A respirator helps standardize the patient on a more reproducible breathing pattern, but deviations would ideally still be handled through the use of multiple plans and dynamic plan switching. In some cases, it may also be that the patient's active breathing in conjunction with a ventilator are adequate to deliver a three-dimensional (“3D”) plan.
F. Quality Assurance Module
Another aspect of some constructions of the system 10 is the provision of various techniques for quality assurance and verification. For example, one such technique for the quality assurance module 146 applicable to validation in phantoms is to develop plans that are intentionally different, such that the plan being delivered is readily determined with external measurement devices, such as ion chambers, scintillation fluid, film, thermoluminescent dosimeters (“TLDs”), diode detectors, flat-panel imagers, or other radiation detectors or monitors. Then by changing the motion-response curve, the system verifies how quickly and appropriately the plan change responds.
In another implementation, the quality assurance module 146 performs validation that can be applied to both patients and phantoms by dose recalculation in a 4D image set based upon the recorded motion trace from the treatment. The dose accumulated across the 4D images provides the net delivered dose, ideally adjusted for deformation. This dose is compared to doses measured at points inside, on, or separate from the patient to validate the net dosimetric effect and that both moving and non-moving regions are handled correctly. This aspect of 4D dose calculation based upon a measured motion pattern can likewise be applied to other deliveries besides the free-breathing adjusted deliveries described herein.
After the treatment plans have been stored in the radiation therapy device 18 (or computer 62), radiation therapy treatment of the patient 14 can begin. In the first stage of treatment, movement patterns are monitored and evaluated (block 312). As described above, the movement patterns can be measured using the movement detection devices 89 and the acquisition module 94, for example. After monitoring the patterns of motion, a list of potential treatment plans can be generated based on the motion pattern (block 316). A treatment plan can be evaluated according to the time and spatial relationships between the plan and the motion pattern of the patient 14. After the list of potential treatment plans is determined, a treatment plan or a combination of treatment plans can be selected (block 320). The treatment plans can be chosen automatically according to the computer 62, or manually by a doctor or other professional. The plan or combination of plans that most closely matches the motion of the region of interest is generally selected. After selecting a treatment plan, it can be evaluated (block 324). Evaluation parameters can include information relating to the position of the region of interest, the deformation of the region of interest, the dose being administered, or a combination thereof. In some embodiments, if the plan that is selected in block 320 is evaluated (e.g., by the quality assurance module 146) and it is not deemed to be an effective treatment, the process can return to block 316 to re-evaluate potential treatments plans to deliver.
If, however, the treatment plan is evaluated and it is projected to have the intended result, it can be delivered by the radiation therapy device 18 (block 328). During delivery of the plan, the process can return, and the subsequent acts can be repeated. In other implementations, after a plan is delivered it is verified (block 332). Delivery verification can be used to determine the dose of radiation that was actually delivered to the patient 14 as well as the deformation that occurred. As described above, the dose and deformation information can have an impact on which plans are subsequently implemented. After the delivery of the plan is verified, the process can return to the plan generation stage at block 300, and the process can be repeated. In other implementations, the process is returned to the motion evaluation block 312, and the remainder of the process is repeated.
As previously stated, an example radiation therapy treatment system capable of incorporating the invention is the HI-ART brand radiation therapy treatment system offered by TomoTherapy, Inc. with a website at www.tomotherapy.com. The TOMOTHERAPY HI-ART brand system is an example of a helical radiation therapy treatment system, which is superior to a conventional IMRT in many aspects. The delivery of helical coplanar intensity modulated beams is one example advantage. In one embodiment, the helical delivery system typically has the following features: 1. fixed jaw width, 2. fixed jaw position and orientation, 3. constant couch speed, 4. constant gantry rotation speed, and 5) one dimensional (1D) binary MLCs for intensity modulation.
But on the other hand, such simplicity in the delivery system also posts some limitations in the situation of a moving region of interest (e.g., target motion results from respiratory motion). Conventional gating and tracking techniques for the moving region of interest may not be easily implemented in the helical system. For example, gating technique requires stopping gantry rotation or couch movement. The tracking technique requires real time jaw tilting. BSD is attractive if the patient follows the planned breathing pattern at all times. But it is hard for the helical system to correct any out-of-phase-breathing.
For one construction of a modified helical system, the system assumes the following: 1. the target position can be real time determined; 2. the target motion is rigid body motion, the deformation, if any, is negligible compared to the rigid body motion; and 3. the target motion within one projection is negligible. Assumption 1 is feasible through the combination of a 4D representation of the pre-treatment patient body (such as 4D CT), and real time phase determination techniques (such as using camera, spirometer or treatment beam as presented above). Assumption 2 is reasonable for most cases. This is also the basic assumption for the tracking technique used in conventional IMRT. Assumption 3 is actually the time resolution of some delivery systems, such as the HI-ART system provided by TomoTherapy, Inc.
The helical delivery, in some constructions, is projection-wised. Each projection is indicated by three parameters:
k is the rotation index (k is an integer number);
φ is the gantry angel (φ ε[0,2π]); and
p is the MLC leaf index
The pair (k,φ) is composed of the projection index. The time t is linearly proportional to projection index t=t(k,φ).
Let ΔZ be the couch proceeding per rotation. Then couch position is
Let I=I(k,φ,p) be the planning sinogram. The function value I(k,φ,p) represents the beam-on time for leaf p at projection (k,φ). The planning itself can be based on a static patient model (3D plan) or BSD model (4D plan).
Let I′=I′(k,φ,p) be the delivery sinogram. One objective of this subsection is to determine the I′=I′(k,φ,p) in case of the moving target.
Let:
One can further decompose the transversal target displacement to a perpendicular-to-beam direction (parallel to MLC line) component u⊥ and to a parallel-to-beam direction component u∥. The result is:
u⊥(k,φ)=ux(k,φ)cos φ+uy(k,φ)sin φ [e3]
u∥(k,φ)=ux(k,φ)sin φ+uy(k,φ)cos φ [e4]
For the parallel-to-beam direction motion component u□, one needs inverse square correction and attenuation correction. Let the correction factor be r
r(k,φ)=r1(k,φ)r2(k,φ) [e5]
where r1(k,φ) is inverse square correction. Let s(k,φ) be the planning source to target distance,
And let r2(k,φ) be the attenuation correction:
Equation [e7] is feasible only if the system has 4D CT, otherwise, the system has to use some other approximations.
The in plane perpendicular-to-beam direction motion component u⊥ is correctable by shifting the MLC pattern. That is
p′(k,φ)=p(k,φ)+u⊥(k,φ) [e8]
To correct the z component motion, one needs to shift the projection. Also, one has to keep the same gantry angle as planning sinogram so that the RAR has the optimal spacing as planned. Therefore, we only need to change the rotation index k
It is also possible that due to arbitrary motion pattern, several projections will map to the same projection and some projections are not mapped at all. One has to consider letting the maximum achievable beam on time for each projection be Imax, such that the delivery strategy for an arbitrary moving target 54 is as illustrated by following pseudo code.
Thus, the invention provides, among other things, new and useful systems and methods of delivering radiation therapy to a moving region of interest. Various features and advantages of the invention are set forth in the following claims.
This application claims the benefit of U.S. Provisional Patent Application No. 60/701,541; titled SYSTEM AND METHOD OF DELIVERING RADIATION THERAPY TO A MOVING TARGET; filed on Jul. 22, 2005; and the benefit of U.S. Provisional Patent Application No. 60/701,580; filed Jul. 22, 2005; titled SYSTEM AND METHOD FOR FEEDBACK GUIDED QUALITY ASSURANCE AND ADAPTATIONS TO RADIATION THERAPY TREATMENT; both of which are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
3949265 | Holl | Apr 1976 | A |
3964467 | Rose | Jun 1976 | A |
4006422 | Schriber | Feb 1977 | A |
4032810 | Eastham et al. | Jun 1977 | A |
4149081 | Seppi | Apr 1979 | A |
4181894 | Pottier | Jan 1980 | A |
4189470 | Rose | Feb 1980 | A |
4208185 | Sawai et al. | Jun 1980 | A |
4273867 | Lin et al. | Jun 1981 | A |
4314180 | Salisbury | Feb 1982 | A |
4335465 | Christiansen et al. | Jun 1982 | A |
4388560 | Robinson et al. | Jun 1983 | A |
4393334 | Glaser | Jul 1983 | A |
4395631 | Salisbury | Jul 1983 | A |
4401765 | Craig et al. | Aug 1983 | A |
4426582 | Orloff et al. | Jan 1984 | A |
4446403 | Cuomo et al. | May 1984 | A |
4455609 | Inamura et al. | Jun 1984 | A |
4480042 | Craig et al. | Oct 1984 | A |
4570103 | Schoen | Feb 1986 | A |
4664869 | Mirzadeh et al. | May 1987 | A |
4703018 | Craig et al. | Oct 1987 | A |
4715056 | Vlasbloem et al. | Dec 1987 | A |
4736106 | Kashy et al. | Apr 1988 | A |
4752692 | Jergenson et al. | Jun 1988 | A |
4754760 | Fukukita et al. | Jul 1988 | A |
4815446 | McIntosh | Mar 1989 | A |
4818914 | Brodie | Apr 1989 | A |
4868844 | Nunan | Sep 1989 | A |
4870287 | Cole et al. | Sep 1989 | A |
4879518 | Broadhurst | Nov 1989 | A |
4912731 | Nardi | Mar 1990 | A |
4936308 | Fukukita et al. | Jun 1990 | A |
4987309 | Klasen et al. | Jan 1991 | A |
4998268 | Winter | Mar 1991 | A |
5003998 | Collett | Apr 1991 | A |
5008907 | Norman et al. | Apr 1991 | A |
5012111 | Ueda | Apr 1991 | A |
5044354 | Goldhorn et al. | Sep 1991 | A |
5065315 | Garcia | Nov 1991 | A |
5073913 | Martin | Dec 1991 | A |
5084682 | Swenson et al. | Jan 1992 | A |
5107222 | Tsuzuki | Apr 1992 | A |
5117829 | Miller et al. | Jun 1992 | A |
5124658 | Adler | Jun 1992 | A |
5210414 | Wallace et al. | May 1993 | A |
5250388 | Schoch et al. | Oct 1993 | A |
5317616 | Swerdloff et al. | May 1994 | A |
5332908 | Weidlich | Jul 1994 | A |
5335255 | Seppi et al. | Aug 1994 | A |
5346548 | Mehta | Sep 1994 | A |
5351280 | Swerdloff et al. | Sep 1994 | A |
5382914 | Hamm et al. | Jan 1995 | A |
5391139 | Edmundson | Feb 1995 | A |
5394452 | Swerdloff et al. | Feb 1995 | A |
5405309 | Carden | Apr 1995 | A |
5442675 | Swerdloff et al. | Aug 1995 | A |
5446548 | Gerig et al. | Aug 1995 | A |
5453310 | Andersen et al. | Sep 1995 | A |
5466587 | Fitzpatrick-McElligott et al. | Nov 1995 | A |
5471516 | Nunan | Nov 1995 | A |
5483122 | Derbenev et al. | Jan 1996 | A |
5489780 | Diamondis | Feb 1996 | A |
5511549 | Legg et al. | Apr 1996 | A |
5523578 | Herskovic | Jun 1996 | A |
5528650 | Swerdloff et al. | Jun 1996 | A |
5548627 | Swerdloff et al. | Aug 1996 | A |
5552605 | Arata | Sep 1996 | A |
5576602 | Hiramoto et al. | Nov 1996 | A |
5578909 | Billen | Nov 1996 | A |
5579358 | Lin | Nov 1996 | A |
5581156 | Roberts et al. | Dec 1996 | A |
5596619 | Carol | Jan 1997 | A |
5596653 | Kurokawa | Jan 1997 | A |
5621779 | Hughes et al. | Apr 1997 | A |
5622187 | Carol | Apr 1997 | A |
5625663 | Swerdloff et al. | Apr 1997 | A |
5627041 | Shartle | May 1997 | A |
5641584 | Andersen et al. | Jun 1997 | A |
5647663 | Holmes | Jul 1997 | A |
5651043 | Tsuyuki et al. | Jul 1997 | A |
5661377 | Mishin et al. | Aug 1997 | A |
5661773 | Swerdloff et al. | Aug 1997 | A |
5667803 | Paronen et al. | Sep 1997 | A |
5668371 | Deasy et al. | Sep 1997 | A |
5673300 | Reckwerdt et al. | Sep 1997 | A |
5692507 | Seppi et al. | Dec 1997 | A |
5695443 | Brent et al. | Dec 1997 | A |
5712482 | Gaiser et al. | Jan 1998 | A |
5721123 | Hayes et al. | Feb 1998 | A |
5724400 | Swerdloff et al. | Mar 1998 | A |
5729028 | Rose | Mar 1998 | A |
5734168 | Yao | Mar 1998 | A |
5747254 | Pontius | May 1998 | A |
5751781 | Brown et al. | May 1998 | A |
5753308 | Andersen et al. | May 1998 | A |
5754622 | Hughes | May 1998 | A |
5754623 | Seki | May 1998 | A |
5760395 | Johnstone | Jun 1998 | A |
5802136 | Carol | Sep 1998 | A |
5811944 | Sampayan et al. | Sep 1998 | A |
5815547 | Shepherd et al. | Sep 1998 | A |
5818058 | Nakanishi et al. | Oct 1998 | A |
5818902 | Yu | Oct 1998 | A |
5820553 | Hughes | Oct 1998 | A |
5821051 | Androphy et al. | Oct 1998 | A |
5821705 | Caporaso et al. | Oct 1998 | A |
5823192 | Kalend et al. | Oct 1998 | A |
5834454 | Kitano et al. | Nov 1998 | A |
5835562 | Ramsdell et al. | Nov 1998 | A |
5836905 | Lemelson et al. | Nov 1998 | A |
5842175 | Andros et al. | Nov 1998 | A |
5866912 | Slater et al. | Feb 1999 | A |
5870447 | Powell et al. | Feb 1999 | A |
5877023 | Sautter et al. | Mar 1999 | A |
5877192 | Lindberg et al. | Mar 1999 | A |
5912134 | Shartle | Jun 1999 | A |
5920601 | Nigg et al. | Jul 1999 | A |
5949080 | Ueda et al. | Sep 1999 | A |
5953461 | Yamada | Sep 1999 | A |
5962995 | Avnery | Oct 1999 | A |
5963615 | Egley et al. | Oct 1999 | A |
5969367 | Hiramoto et al. | Oct 1999 | A |
5977100 | Kitano et al. | Nov 1999 | A |
5983424 | Naslund | Nov 1999 | A |
5986274 | Akiyama et al. | Nov 1999 | A |
6011825 | Welch et al. | Jan 2000 | A |
6020135 | Levine et al. | Feb 2000 | A |
6020538 | Han et al. | Feb 2000 | A |
6029079 | Cox et al. | Feb 2000 | A |
6038283 | Carol et al. | Mar 2000 | A |
6049587 | Leksell et al. | Apr 2000 | A |
6066927 | Koudijs | May 2000 | A |
6069459 | Koudijs | May 2000 | A |
6071748 | Modlin et al. | Jun 2000 | A |
6094760 | Nonaka et al. | Aug 2000 | A |
6127688 | Wu | Oct 2000 | A |
6144875 | Schweikard et al. | Nov 2000 | A |
6152599 | Salter | Nov 2000 | A |
6171798 | Levine et al. | Jan 2001 | B1 |
6178345 | Vilsmeier et al. | Jan 2001 | B1 |
6197328 | Yanagawa | Mar 2001 | B1 |
6198957 | Green | Mar 2001 | B1 |
6200959 | Haynes et al. | Mar 2001 | B1 |
6204510 | Ohkawa | Mar 2001 | B1 |
6207400 | Kwon | Mar 2001 | B1 |
6218675 | Akiyama et al. | Apr 2001 | B1 |
6222905 | Yoda et al. | Apr 2001 | B1 |
6241670 | Nambu | Jun 2001 | B1 |
6242747 | Sugitani et al. | Jun 2001 | B1 |
6264825 | Blackburn et al. | Jul 2001 | B1 |
6265837 | Akiyama et al. | Jul 2001 | B1 |
6279579 | Riaziat et al. | Aug 2001 | B1 |
6291823 | Doyle et al. | Sep 2001 | B1 |
6301329 | Surridge | Oct 2001 | B1 |
6316776 | Hiramoto et al. | Nov 2001 | B1 |
6319469 | Mian et al. | Nov 2001 | B1 |
6322249 | Wofford et al. | Nov 2001 | B1 |
6331194 | Elizondo-Decanini et al. | Dec 2001 | B1 |
6345114 | Mackie et al. | Feb 2002 | B1 |
6360116 | Jackson, Jr. et al. | Mar 2002 | B1 |
6385286 | Fitchard et al. | May 2002 | B1 |
6385288 | Kanematsu | May 2002 | B1 |
6393096 | Carol et al. | May 2002 | B1 |
6405072 | Cosman | Jun 2002 | B1 |
6407505 | Bertsche | Jun 2002 | B1 |
6417178 | Klunk et al. | Jul 2002 | B1 |
6424856 | Vilsmeier et al. | Jul 2002 | B1 |
6428547 | Vilsmeier et al. | Aug 2002 | B1 |
6433349 | Akiyama et al. | Aug 2002 | B2 |
6438202 | Olivera et al. | Aug 2002 | B1 |
6455844 | Meyer | Sep 2002 | B1 |
6462490 | Matsuda et al. | Oct 2002 | B1 |
6465957 | Whitham et al. | Oct 2002 | B1 |
6466644 | Hughes et al. | Oct 2002 | B1 |
6469058 | Grove et al. | Oct 2002 | B1 |
6472834 | Hiramoto et al. | Oct 2002 | B2 |
6473490 | Siochi | Oct 2002 | B1 |
6475994 | Tomalia et al. | Nov 2002 | B2 |
6477229 | Grosser | Nov 2002 | B1 |
6482604 | Kwon | Nov 2002 | B2 |
6484049 | Seeley et al. | Nov 2002 | B1 |
6484144 | Martin et al. | Nov 2002 | B2 |
6487274 | Bertsche | Nov 2002 | B2 |
6493424 | Whitham | Dec 2002 | B2 |
6497358 | Walsh | Dec 2002 | B1 |
6498011 | Hohn et al. | Dec 2002 | B2 |
6500343 | Siddiqi | Dec 2002 | B2 |
6504899 | Pugachev et al. | Jan 2003 | B2 |
6510199 | Hughes et al. | Jan 2003 | B1 |
6512942 | Burdette et al. | Jan 2003 | B1 |
6516046 | Frohlich et al. | Feb 2003 | B1 |
6527443 | Vilsmeier et al. | Mar 2003 | B1 |
6530873 | Lee | Mar 2003 | B1 |
6531449 | Khojasteh et al. | Mar 2003 | B2 |
6535837 | Schach Von Wittenau | Mar 2003 | B1 |
6552338 | Doyle | Apr 2003 | B1 |
6558961 | Sarphie et al. | May 2003 | B1 |
6560311 | Shepard et al. | May 2003 | B1 |
6562376 | Hooper et al. | May 2003 | B2 |
6584174 | Schubert et al. | Jun 2003 | B2 |
6586409 | Wheeler | Jul 2003 | B1 |
6605297 | Nadachi et al. | Aug 2003 | B2 |
6611700 | Vilsmeier et al. | Aug 2003 | B1 |
6617768 | Hansen | Sep 2003 | B1 |
6618467 | Ruchala et al. | Sep 2003 | B1 |
6621889 | Mostafavi | Sep 2003 | B1 |
6633686 | Bakircioglu et al. | Oct 2003 | B1 |
6634790 | Salter, Jr. | Oct 2003 | B1 |
6636622 | Mackie et al. | Oct 2003 | B2 |
6637056 | Tybinkowski et al. | Oct 2003 | B1 |
6646383 | Bertsche et al. | Nov 2003 | B2 |
6653547 | Akamatsu | Nov 2003 | B2 |
6661870 | Kapatoes et al. | Dec 2003 | B2 |
6688187 | Masquelier | Feb 2004 | B1 |
6690965 | Riaziat et al. | Feb 2004 | B1 |
6697452 | Feb 2004 | B2 | |
6705984 | Angha | Mar 2004 | B1 |
6713668 | Akamatsu | Mar 2004 | B2 |
6713976 | Zumoto et al. | Mar 2004 | B1 |
6714620 | Caflisch et al. | Mar 2004 | B2 |
6714629 | Vilsmeier | Mar 2004 | B2 |
6716162 | Hakamata | Apr 2004 | B2 |
6723334 | McGee et al. | Apr 2004 | B1 |
6741674 | Lee | May 2004 | B2 |
6760402 | Ghelmansarai | Jul 2004 | B2 |
6774383 | Norimine et al. | Aug 2004 | B2 |
6787771 | Garty et al. | Sep 2004 | B2 |
6787983 | Yamanobe et al. | Sep 2004 | B2 |
6788764 | Saladin et al. | Sep 2004 | B2 |
6792073 | Deasy et al. | Sep 2004 | B2 |
6796164 | McLoughlin et al. | Sep 2004 | B2 |
6800866 | Amemiya et al. | Oct 2004 | B2 |
6822244 | Beloussov et al. | Nov 2004 | B2 |
6822247 | Sasaki | Nov 2004 | B2 |
6838676 | Jackson | Jan 2005 | B1 |
6842502 | Jaffray et al. | Jan 2005 | B2 |
6844689 | Brown et al. | Jan 2005 | B1 |
6871171 | Agur et al. | Mar 2005 | B1 |
6873115 | Sagawa et al. | Mar 2005 | B2 |
6873123 | Marchand et al. | Mar 2005 | B2 |
6878951 | Ma | Apr 2005 | B2 |
6882702 | Luo | Apr 2005 | B2 |
6882705 | Egley et al. | Apr 2005 | B2 |
6888326 | Amaldi et al. | May 2005 | B2 |
6889695 | Pankratov et al. | May 2005 | B2 |
6920203 | Short et al. | Jul 2005 | B2 |
6922455 | Jurczyk et al. | Jul 2005 | B2 |
6929398 | Tybinkowski et al. | Aug 2005 | B1 |
6936832 | Norimine et al. | Aug 2005 | B2 |
6955464 | Tybinkowski et al. | Oct 2005 | B1 |
6963171 | Sagawa et al. | Nov 2005 | B2 |
6974254 | Paliwal et al. | Dec 2005 | B2 |
6977984 | Hsieh | Dec 2005 | B2 |
6984835 | Harada | Jan 2006 | B2 |
6990167 | Chen | Jan 2006 | B2 |
7015490 | Wang et al. | Mar 2006 | B2 |
7046762 | Lee | May 2006 | B2 |
7051605 | Lagraff et al. | May 2006 | B2 |
7054413 | Steinberg | May 2006 | B2 |
7060997 | Norimine et al. | Jun 2006 | B2 |
7077569 | Tybinkowski et al. | Jul 2006 | B1 |
7081619 | Bashkirov et al. | Jul 2006 | B2 |
7084410 | Beloussov et al. | Aug 2006 | B2 |
7087200 | Taboas et al. | Aug 2006 | B2 |
7112924 | Hanna | Sep 2006 | B2 |
7116749 | Besson | Oct 2006 | B2 |
7130372 | Kusch et al. | Oct 2006 | B2 |
7154991 | Earnst et al. | Dec 2006 | B2 |
7177386 | Mostafavi et al. | Feb 2007 | B2 |
7186986 | Hinderer et al. | Mar 2007 | B2 |
7186991 | Kato et al. | Mar 2007 | B2 |
7203272 | Chen | Apr 2007 | B2 |
7209547 | Baier et al. | Apr 2007 | B2 |
7221729 | Wakai et al. | May 2007 | B2 |
7221733 | Takai et al. | May 2007 | B1 |
7252307 | Kanbe et al. | Aug 2007 | B2 |
7257196 | Brown et al. | Aug 2007 | B2 |
7265356 | Pelizzari et al. | Sep 2007 | B2 |
7302033 | Carrano et al. | Nov 2007 | B2 |
7302038 | Mackie et al. | Nov 2007 | B2 |
7382858 | Gohno | Jun 2008 | B2 |
7391026 | Trinkaus et al. | Jun 2008 | B2 |
7444011 | Pan et al. | Oct 2008 | B2 |
7450687 | Yeo et al. | Nov 2008 | B2 |
7492858 | Partain et al. | Feb 2009 | B2 |
7551717 | Tome et al. | Jun 2009 | B2 |
7613501 | Scherch | Nov 2009 | B2 |
7983380 | Guertin et al. | Jul 2011 | B2 |
20020007918 | Owen et al. | Jan 2002 | A1 |
20020077545 | Takahashi et al. | Jun 2002 | A1 |
20020080915 | Frohlich | Jun 2002 | A1 |
20020085668 | Blumhofer et al. | Jul 2002 | A1 |
20020091314 | Schlossbauer et al. | Jul 2002 | A1 |
20020115923 | Erbel | Aug 2002 | A1 |
20020120986 | Erbel et al. | Sep 2002 | A1 |
20020122530 | Erbel et al. | Sep 2002 | A1 |
20020136439 | Ruchala et al. | Sep 2002 | A1 |
20020150207 | Kapatoes et al. | Oct 2002 | A1 |
20020187502 | Waterman et al. | Dec 2002 | A1 |
20020193685 | Mate et al. | Dec 2002 | A1 |
20030007601 | Jaffray et al. | Jan 2003 | A1 |
20030031298 | Feb 2003 | A1 | |
20030048868 | Bailey et al. | Mar 2003 | A1 |
20030086527 | Speiser et al. | May 2003 | A1 |
20030105650 | Lombardo et al. | Jun 2003 | A1 |
20030112922 | Burdette et al. | Jun 2003 | A1 |
20030174872 | Chalana et al. | Sep 2003 | A1 |
20040010418 | Buonocore et al. | Jan 2004 | A1 |
20040024300 | Graf | Feb 2004 | A1 |
20040068182 | Misra | Apr 2004 | A1 |
20040071337 | Jeung et al. | Apr 2004 | A1 |
20040096033 | Seppi et al. | May 2004 | A1 |
20040116804 | Mostafavi | Jun 2004 | A1 |
20040120452 | Shapiro et al. | Jun 2004 | A1 |
20040165696 | Lee | Aug 2004 | A1 |
20040202280 | Besson | Oct 2004 | A1 |
20040230115 | Scarantino et al. | Nov 2004 | A1 |
20040254448 | Amies et al. | Dec 2004 | A1 |
20040254492 | Zhang et al. | Dec 2004 | A1 |
20040254773 | Zhang et al. | Dec 2004 | A1 |
20040264640 | Myles | Dec 2004 | A1 |
20050008121 | Low et al. | Jan 2005 | A1 |
20050013406 | Dyk et al. | Jan 2005 | A1 |
20050031181 | Bi et al. | Feb 2005 | A1 |
20050080332 | Shiu et al. | Apr 2005 | A1 |
20050096515 | Geng | May 2005 | A1 |
20050123092 | Mistretta et al. | Jun 2005 | A1 |
20050143965 | Failla et al. | Jun 2005 | A1 |
20050161051 | Pankratov et al. | Jul 2005 | A1 |
20050171396 | Pankratov et al. | Aug 2005 | A1 |
20050180544 | Sauer et al. | Aug 2005 | A1 |
20050197564 | Dempsey | Sep 2005 | A1 |
20050201515 | Mitschke | Sep 2005 | A1 |
20050201516 | Ruchala et al. | Sep 2005 | A1 |
20050251029 | Khamene et al. | Nov 2005 | A1 |
20060074292 | Thomson et al. | Apr 2006 | A1 |
20060078086 | Riley et al. | Apr 2006 | A1 |
20060083349 | Harari et al. | Apr 2006 | A1 |
20060100738 | Alsafadi et al. | May 2006 | A1 |
20060133568 | Moore | Jun 2006 | A1 |
20060153330 | Wong et al. | Jul 2006 | A1 |
20060173294 | Ein-Gal | Aug 2006 | A1 |
20060193429 | Chen | Aug 2006 | A1 |
20060193441 | Cadman | Aug 2006 | A1 |
20060241332 | Klein et al. | Oct 2006 | A1 |
20060285639 | Olivera et al. | Dec 2006 | A1 |
20060285640 | Nizin et al. | Dec 2006 | A1 |
20060293583 | Saracen et al. | Dec 2006 | A1 |
20070041494 | Ruchala et al. | Feb 2007 | A1 |
20070041495 | Olivera et al. | Feb 2007 | A1 |
20070041496 | Olivera et al. | Feb 2007 | A1 |
20070041497 | Schnarr et al. | Feb 2007 | A1 |
20070041498 | Olivera et al. | Feb 2007 | A1 |
20070041499 | Lu et al. | Feb 2007 | A1 |
20070041500 | Olivera et al. | Feb 2007 | A1 |
20070043286 | Lu et al. | Feb 2007 | A1 |
20070076846 | Ruchala et al. | Apr 2007 | A1 |
20070088573 | Ruchala et al. | Apr 2007 | A1 |
20070104316 | Ruchala et al. | May 2007 | A1 |
20070127623 | Goldman et al. | Jun 2007 | A1 |
20070127790 | Lau et al. | Jun 2007 | A1 |
20070156453 | Frielinghaus et al. | Jul 2007 | A1 |
20070189591 | Lu et al. | Aug 2007 | A1 |
20070195922 | Mackie et al. | Aug 2007 | A1 |
20070195929 | Ruchala et al. | Aug 2007 | A1 |
20070195930 | Kapatoes et al. | Aug 2007 | A1 |
20070197908 | Ruchala et al. | Aug 2007 | A1 |
20070201613 | Lu et al. | Aug 2007 | A1 |
20070211857 | Urano et al. | Sep 2007 | A1 |
20080002809 | Bodduluri | Jan 2008 | A1 |
20080002811 | Allison | Jan 2008 | A1 |
20080031406 | Yan et al. | Feb 2008 | A1 |
20080049896 | Kuduvalli | Feb 2008 | A1 |
20080049898 | Romesberg et al. | Feb 2008 | A1 |
20080064953 | Falco | Mar 2008 | A1 |
20080279328 | Zeitler et al. | Nov 2008 | A1 |
20090041200 | Lu et al. | Feb 2009 | A1 |
20090116616 | Lu et al. | May 2009 | A1 |
20090121144 | Black et al. | May 2009 | A1 |
20090252291 | Lu et al. | Oct 2009 | A1 |
20100053208 | Menningen et al. | Mar 2010 | A1 |
20100054413 | Sobering et al. | Mar 2010 | A1 |
20100119032 | Yan et al. | May 2010 | A1 |
20110019889 | Gering et al. | Jan 2011 | A1 |
Number | Date | Country |
---|---|---|
2091275 | Sep 1993 | CA |
2180227 | Dec 1996 | CA |
10221634 | Dec 2003 | DE |
259989 | Mar 1988 | EP |
2001161839 | Jun 2001 | JP |
2001340474 | Dec 2001 | JP |
2003523220 | Aug 2003 | JP |
2004166975 | Jun 2004 | JP |
2005518908 | Jun 2005 | JP |
261523 | Sep 2006 | TW |
0007669 | Feb 2000 | WO |
0054689 | Sep 2000 | WO |
03076003 | Sep 2003 | WO |
03092789 | Nov 2003 | WO |
2004057515 | Jul 2004 | WO |
2004066211 | Aug 2004 | WO |
2004105574 | Dec 2004 | WO |
2005057463 | Jun 2005 | WO |
Number | Date | Country | |
---|---|---|---|
20070201613 A1 | Aug 2007 | US |
Number | Date | Country | |
---|---|---|---|
60701541 | Jul 2005 | US | |
60701580 | Jul 2005 | US |